Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Pooya Hemami

Pooya Hemami
Analyst

Dr Charlotte Hetzel

Dr Charlotte Hetzel
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Alice Nettleton

Alice Nettleton
Healthcare Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Andy Smith

Andy Smith

Briana Warschun

Briana Warschun
Associate Healthcare Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

Clal Biotechnology Industries Targovax
ASLAN Pharmaceuticals Cellular Biomedicine Group
Sierra Oncology Laboratorios Farmacéuticos ROVI

Recent QuickViews

aap Implantate

Preliminary FY17 sales in line with guidance

Pharmaceutical & healthcare | published 21/02/2018
Smith & Nephew

Challenges being addressed

Pharmaceutical & healthcare | published 12/02/2018
Bionomics

A novel method of treating anxiety disorders

Pharmaceutical & healthcare | published 18/12/2017
aap Implantate

Focus is the key foundation

Pharmaceutical & healthcare | published 28/11/2017

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

MagForce

US NanoTherm IDE approval a major milestone

Update | Pharmaceutical & healthcare | 23/02/2018

MagForce has received IDE approval to start its first pivotal clinical trial evaluating NanoTherm focal ablation therapy for prostate cancer in the US.…

TxCell

Robust and stable Treg manufacturing

Outlook | Pharmaceutical & healthcare | 22/02/2018

TxCell has disclosed that it has a viable manufacturing route for its novel CAR Treg products. This uses a stable but low-frequency Treg cell type. The…

Oxford BioMedica

LentiVector platform expanding into haemophilia

Flash note | Pharmaceutical & healthcare | 16/02/2018

Oxford BioMedica (OXB) has announced a collaboration and licence agreement with Bioverativ to develop gene therapy products for the treatment of haemophilia.…

ReNeuron Group

Consolidation confusion?

Update | Pharmaceutical & healthcare | 14/02/2018

ReNeuron’s recent 100 for 1 share consolidation was a benign and cosmetic ‘tidy up’ of its historical capital structure. The share price…

4SC

Steady R&D newsflow

Update | Pharmaceutical & healthcare | 09/02/2018

Over the past several months 4SC has reported progress with both its clinical-stage assets – resminostat and 4SC-202. The pivotal trial with resminostat…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies